Home
Swixx Biopharma AG

Swixx Biopharma AG Market Share Analysis for July 2026

Notification to Individuals Regarding the Processing of Personal Data

Industry: N/A

Domainswixxbiopharma.com

Year Founded2014

Employees1001 - 5000

Annual Revenue$200M - $500M

Swixx Biopharma AG

Swixx Biopharma AG (including company regionals)

swixxbiopharma.com

See more website traffic and engagement information

Swixx Biopharma AG Revenue up to July 2026 is 200M - 500M

revenue generated by Swixx Biopharma AG top domains

Swixx Biopharma AG top domains revenue over 3 years

Revenue for Swixx Biopharma AG top domains

swixxbiopharma.com200M - 500M

See more with Sales Intelligence

Total visits to Swixx Biopharma AG's top domains

Understand Swixx Biopharma AG market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

swixxbiopharma.com5.9K

See more with Sales Intelligence

Avg. visit duration in Swixx Biopharma AG's top domains

Analyze Swixx Biopharma AG engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

swixxbiopharma.com00:00:07

See more with Sales Intelligence

Avg. pageviews on Swixx Biopharma AG's top domains

See how Swixx Biopharma AG keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

swixxbiopharma.com1.73

See more with Sales Intelligence

Swixx Biopharma AG top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Swixx Biopharma AG

These are the website technologies, by industry, used by Swixx Biopharma AG top domains

Social (3)

Instagram

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

Advertising (1)

DoubleClick

More Technologies

6

See all

News & Signals from Swixx Biopharma AG

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBain Capital, LP acquired Swixx Biopharma SA on Jun 1st '26.HBM Healthcare Investments today announced the successful closing of the previously disclosed transaction, in which funds advised by SK Capital Partners and Bain Capital Life Sciences acquired a majority equity interest in Swixx Biopharma from HBM Healthcare Investments and certain other existing shareholders.

NewsSK Capital Partners, LP acquires Swixx Biopharma SA for $1.76B.SK Capital acquires majority stake in Swixx Biopharma at EUR 1.5 billion valuation.

NewsSwixx Biopharma SA expands offices to Middle, New Jersey, United States, Northern America, Americas.Swixx has been working with partners in central and eastern Europe and expanded into the Middle East and Latin America in recent years.